Search for: "International Materials, Inc."
Results 6821 - 6840
of 7,055
Sort by Relevance
|
Sort by Date
27 Feb 2008, 12:11 am
Renfroe & Company, Inc., any of the material delivered to them pursuant to the mandatory injunction without first obtaining the express written approval of the court after in camera inspection. [read post]
26 Feb 2008, 1:10 am
John McCain and John McCain 2008, Inc. [read post]
25 Feb 2008, 10:45 am
, Inc., Superior Court of Paris, May 22, 2000. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
22 Feb 2008, 1:46 pm
International Game Technology, 184 F.3d 1339 (Fed. [read post]
21 Feb 2008, 1:20 pm
A new risk factor also popped up in the 10-K filed by Waste Management Inc. [read post]
21 Feb 2008, 12:34 am
Medtronic, Inc. [read post]
20 Feb 2008, 4:07 am
Relying on the test enunciated by the Supreme Court in Tellabs, Inc. v. [read post]
18 Feb 2008, 5:01 pm
" Applicant, based on its reading of Palm Bay Import, Inc. v. [read post]
18 Feb 2008, 5:15 am
” The primary materials for this case may be found on the DU Corporate Governance website. [read post]
17 Feb 2008, 1:00 pm
At Controversial Patent Upheld in Amended Form, Reichel discusses and gives relevant links to the "frozen sperm" patent of XY Inc. of Colorado, showing the lengths to which the issuance of patents has extended.Reichel in USPTO Announces New Duty of Disclosure Declaration Requirement points to the new disclosure rule effective June 1, 2008 requiring the use of the phrase "material to patentability" rather than "material to the examination" in… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
7 Feb 2008, 10:46 am
Id. at 230 (FDA "d[id] not include" Plaintiffs' claimed requirement); 230 (Plaintiffs' claim "at best a tenuous assertion and, at worst, an outright mischaracterization of the record"); 230 ("the record flatly contradicts plaintiffs' position"); 231 (describing "specious nature of plaintiffs' claim"); 231-32 (claims based upon "inapplicable" materials). [read post]
4 Feb 2008, 12:42 am
Selected federal documents below from Gallery Watch.com may include references to government reporrts, Congressional letters, draft bills, and other primary source materials. [read post]
2 Feb 2008, 1:03 pm
Detecon, Inc., No. 06-2092 (4th Cir., Jan. 31, 2008) (PDF), the Fourth Circuit held that an employee did not have show a "materially adverse" employment action in order to make out a retaliation claim under the FLSA.After Detecon, Inc., a small wireless telecommunications consulting company, discharged one of its officers, Larry Darveau, he sued, alleging that Detecon had not paid him overtime in violation of the Fair Labor Standards Act. [read post]
1 Feb 2008, 9:27 am
Hein and Company, Inc.: 1. [read post]
1 Feb 2008, 1:07 am
Selected federal documents below from Gallery Watch.com may include references to government reporrts, Congressional letters, draft bills, and other primary source materials. [read post]
31 Jan 2008, 12:22 am
Selected federal documents below from Gallery Watch.com may include references to government reporrts, Congressional letters, draft bills, and other primary source materials. [read post]
30 Jan 2008, 5:34 pm
The Bureau of Industry and Security (”BIS”) released, on January 23, a settlement agreement under which freight forwarder Elite International Transportation, Inc. agreed to pay $156,000 in penalties for export violations. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
